Laboratory research materials for in vitro use only.

VIP

For laboratory research use only (in vitro). Not for human or animal use.

$100.99

Volume Pricing

QuantityDiscountUnit Price
1-2 unitsStandard$100.99
3-4 units5% off$95.94
5-9 units10% off$90.89
10+ units Best Value15% off$85.84

Why researchers choose PBC:

  • HPLC-verified purity on every lot
  • Certificate of Analysis included
  • Temperature-controlled shipping
  • Canadian lab — documented supply chain
  • Batch-level traceability

Accepted payment methods:

InteracVisaMCCrypto

Certificate of Analysis available upon request. Contact us for lot-specific documentation.

Product Specifications

Amino Acid Sequence His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn
Molecular Weight 3326.8 Da
Molecular Formula C147H237N43O43S1
CAS Number 37221-79-7
Purity ≥98% (HPLC)
Format Lyophilized Powder
Net Quantity 10mg
Vials Per Kit 10
Storage Store at -20C. Reconstituted: 2-8C
Research Status Phase2

For laboratory research use only (in vitro). Not for human or animal use.

Description

Chemical Identity

VIP analytical reference compound. Molecular weight 3326.8 Da.

Specifications

Sequence His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn
Molecular Weight 3326.8 Da
Molecular Formula C147H237N43O43S1
CAS 37221-79-7
Purity >=98% (HPLC)
Format Lyophilized powder
Storage Store at -20C. Reconstituted: 2-8C

For laboratory research use only (in vitro). Not for human or animal use.

Published Research

4 references

References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

Petkov V, Mosgoeller W, Ziesche R, et al. (2003). Journal of Clinical Investigation. PubMed 12727925

ZYESAMI (aviptadil) for COVID-19 respiratory failure (Phase 2/3)

NeuroRx Inc. (2021). ClinicalTrials.gov

VIP in experimental colitis and inflammatory bowel disease models

Abad C, Martinez C, Juarranz MG, et al. (2003). Annals of the New York Academy of Sciences. PubMed 12671893

Neuroprotective effects of VIP in Alzheimer disease models

Gozes I, Brenneman DE (2000). Journal of Molecular Neuroscience. PubMed 10676441

For laboratory research use only (in vitro). Not for human or animal use.

Age Verification Required

You must be 19 years of age or older to access this website. This site contains laboratory research materials restricted to qualified personnel.